Prevention of influenza in the general population: Recommendation statement from the Canadian Task Force on Preventive Health Care

CMAJ. Canadian Medical Association Journal

Volumn 171, Issue 10, 2004, Pages 1169-1170

  Langley, Joanne M ^a,c   Faughnan, Marie E ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c Can Task Force on Prev Health Care   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR; ZANAMIVIR;

CANADA; CHEMOPROPHYLAXIS; DRUG INDICATION; HEALTH CARE POLICY; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; INJECTION PAIN; NAUSEA; PRACTICE GUIDELINE; RHINORRHEA; SHORT SURVEY; SORE THROAT; VOMITING;

EID: 8744236884     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1041375     Document Type: Short Survey

References (12)

1. Glezen WP, Keitel WA, Taber LH, Piedra PA, Clover RD, Couch RB. Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989. Am J Epidemiol 1991;133(3):296-304.
2. Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA 2000;284(13):1655-63.
3. Nichol KL, Lind A, Margolis KL, Murdoch M, McFadden R, Hauge M, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995;333(14):889-93.
4. Nichol KL, Mendelman PM, Mallon KP, Jackson LA, Gorse GJ, Belshe RB, et al. Effectiveness of live, attenuated inttanasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA 1999;282 (2):137-44.
5. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB; Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) [published erratum in MMWR Recomm Rep 2004;53(32):743]. MMWR Recomm Rep 2004;53(RR-6):1-40.
6. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB; Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) [published erratum in MMWR Recomm Rep 2004;53(32):743]. MMWR Recomm Rep 2004;53(RR-6):1-40.
7. National Advisory Committee on Immunization (NACI). An Advisory Committee Statement (ACS). Statement on recommended use of influenza vaccination for the 2002-2003 season. Can Commun Dis Rep 2003;28:1-32.
8. US Preventive Services Task Force. Adult immunizations. In: Guide to clinical preventive health services. 2nd ed. Baltimore: Williams and Wilkins; 1996. p. 791-814.
9. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000;342(4):225-31.
10. Longini IM, Jr., Koopman JS, Monto AS, Fox JP. Estimating household and community transmission parameters for influenza. Am J Epidemiol 1982;115(5):736-51.
11. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001;344(12):889-96.
12. National Advisory Committee on Immunization (NACI). Canadian immunization guide. 6th ed. Ottawa: Canadian Medical Association; 2002. p. 122-4.